• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Aiberry Expands Mental Health AI-Powered Assessment Platform to Cover Major Anxiety Disorders

by Syed Hamza Sohail 11/14/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • Aiberry®, a leading AI-powered mental health assessment platform, today announced that it has expanded its capabilities to include screening for anxiety disorders, in addition to the clinically-validated depression assessments it has provided to date.
  • The comprehensive anxiety screening includes assessments for five distinct anxiety disorders including generalized anxiety disorder, social anxiety disorder, panic disorder, post traumatic stress syndrome (PTSD), and obsessive compulsive disorder (OCD). 

Screening for Anxiety Disorders Added by Aiberry

MedPass, a subscription platform powered by HealthBird that focuses on proactive health management, has formed a partnership with Aiberry to enhance its offerings. Aiberry addresses the growing mental health crisis in the United States, where 18% of Americans experience anxiety annually, leading to significant workplace costs and productivity loss. Aiberry’s Anxiety Screening goes beyond conventional assessments, covering various anxiety disorders and aims to offer more precise mental health assessments through a technology-forward application.

Aiberry employs an AI-powered virtual therapeutic assistant called Botberry, providing quantifiable outcomes and valuable insights into mental health status for users, clinicians, wellness management companies, and now MedPass users. MedPass, known for its proactive health management services, has joined forces with Aiberry to provide a comprehensive mental health solution. MedPass offers a subscription-based membership including telehealth, mental health support, personalized nutrition guidance, and fitness classes, aligning with Aiberry’s goal of reshaping mental health care in the United States. Together, they aim to address the urgent mental health needs of the nation by offering an innovative and holistic approach.

“Aiberry’s commitment to redefining mental health care is unwavering,” said Linda Chung, co-founder and co-CEO of Aiberry. “We recognize the gaps in the current system, and our partnership with innovative companies like HealthBird and MedPass is poised to make a significant impact. We’re acutely aware of the challenges individuals, especially in high stakes industries, face when it comes to mental health. Recent news has highlighted the unfortunate reality that some feel compelled to conceal their struggles due to fears around job security. Our commitment to providing confidential and accessible resources aims to break down these barriers. We believe that no one should have to navigate their mental health journey alone.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |